InvestorsHub Logo
Followers 44
Posts 5550
Boards Moderated 0
Alias Born 11/15/2013

Re: None

Monday, 12/12/2016 8:20:33 PM

Monday, December 12, 2016 8:20:33 PM

Post# of 471242
The wording from PR said they have funds to "prepare" for phase 2/3 AD, Parkinson and Retts syndrome in 2017. Dr Missling has said there would be a partnering for a large placebo controlled phase 2/3 Alzheimer's trial. I for one am waiting for the Biogen results.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News